codavax-h1n1
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 21, 2017 (NCT03926416)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05223179 | Phase 1 | Apr 11, 2022 | Codagenix, Inc |
| NCT03926416 | Phase 1 | Feb 21, 2017 | Codagenix, Inc, Q-Pharm |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Codagenix, Inc | For profit | 2 | 2 | 1 | 2017 |
| Q-Pharm | For profit | 1 | 0 | 1 | 2017 |
2 organizations
Page 1 / 1